Big Pharma is pouring money into tech-devised treatments, but the verdict is out on whether they’ll actually work.
Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, ...
SAN DIEGO, CA, UNITED STATES, May 18, 2026 /EINPresswire.com/ -- Which CRO Is Good at Protein Degradation? Key ...
6don MSNOpinion
Contributor: Fuel drug development, not Big Pharma's profits
More than 200 drugs in the pipeline for ALS are stuck in a system that favors big, slow-moving pharmaceutical companies.
Ultragenyx’s Rare Bootcamp gives families a roadmap to help drive research and develop new treatments for rare diseases.
Formulation development serves as a vital bridge between a drug substance and a drug product that will remain stable and ...
U.S. President Donald Trump's executive order to accelerate psychedelic drug development has raised hopes among companies ...
Researchers at The University of Texas Medical Branch (UTMB) have identified how a key enzyme called ATR protects DNA from ...
A Novartis cross-border partnership is turning into a standoff. | A Novartis cross-border partnership is turning into a ...
Launched with NSF funding this year, Penn’s AIRFoundry boasts the potential to radically speed up drug development.
NASA has enabled scientists to study the impact of microgravity on drug development for decades, beginning with the Space ...
Accelerated drug development expertise. For small startups and academic spinoffs bringing their first molecules to market, reaching the clinic represents a major milestone. Reduci ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results